Skip to main content
. 2019 May 23;18:2325958219849061. doi: 10.1177/2325958219849061

Figure 2.

Figure 2.

Frequency and type of nucleoside reverse transcriptase inhibitor (NRTI) drug-resistant mutation in patients with HIV and tuberculosis (A) and HIV alone (B).